Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review

被引：3
|
作者：
Xu, Jiamin [1 ]
Mu, Shukun [2 ]
Wang, Yun [2 ]
Yu, Suchun [3 ]
Wang, Zhongming [2 ]
机构：
[1] Univ Shanghai Sci & Technol, Sch Hlth Sci & Engn, Shanghai, Peoples R China
[2] Univ Shanghai Sci & Technol, Shidong Hosp Affiliated, Dept Radiat Oncol, Yangpu Dist, Shanghai, Peoples R China
[3] Univ Shanghai Sci & Technol, Shidong Hosp Affiliated, Dept Pharm, Yangpu Dist, Shanghai, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
melanoma; immune checkpoint inhibitors; radiotherapy; combination therapy; oncolytic virus; PLUS IPILIMUMAB; UVEAL MELANOMA; NIVOLUMAB; PEMBROLIZUMAB; RELATLIMAB; CANCER; RESPONSES; OUTCOMES; DISEASE; TRIAL;
D O I：
10.3389/fonc.2024.1400193
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The incidence of melanoma is increasing year by year and is highly malignant, with a poor prognosis. Its treatment has always attracted much attention. Among the more clinically applied immunotherapies are immune checkpoint inhibitors, bispecific antibodies, cancer vaccines, adoptive cell transfer therapy, and oncolytic virotherapy. With the continuous development of technology and trials, in addition to immune monotherapy, combinations of immunotherapy and radiotherapy have shown surprising efficacy. In this article, we review the research progress of immune monotherapy and combination therapy for advanced melanoma, with the aim of providing new ideas for the treatment strategy for advanced melanoma.
引用
收藏
页数：11
相关论文
共 50 条
  • [41] Immune checkpoint modulators in cancer immunotherapy: Recent advances and combination rationales
    Fan, Li
    Li, Yue
    Chen, Jia-Yu
    Zheng, Yong-Fa
    Xu, Xi-Ming
    CANCER LETTERS, 2019, 456 : 23 - 28
  • [42] Recent advances in nanomaterial-based synergistic combination cancer immunotherapy
    Sang, Wei
    Zhang, Zhan
    Dai, Yunlu
    Chen, Xiaoyuan
    CHEMICAL SOCIETY REVIEWS, 2019, 48 (14) : 3771 - 3810
  • [43] Immunotherapy for Advanced Melanoma
    Fang, Lei
    Lonsdorf, Anke S.
    Hwang, Sam T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (11) : 2596 - 2605
  • [44] Combination immunotherapy for high-risk and advanced melanoma patients.
    Riker, A. I.
    Vahanian, N. N.
    Link, C. J.
    Tennant, L.
    Ramsey, W. J.
    Rossi, G. R.
    Alsfeld, L. C.
    Davila, E.
    Harrison, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Endocrine manipulation in advanced breast cancer: Recent advances with SERM therapies
    Johnston, SRD
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4376S - 4387S
  • [46] Advances in immunotherapy for melanoma management
    Dany, Mohammed
    Nganga, Rose
    Chidiac, Alissar
    Hanna, Edith
    Matar, Sara
    Elston, Dirk
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (10) : 2501 - 2511
  • [47] Advances and perspectives in immunotherapy of melanoma
    Schadendorf, D.
    Vaubel, J.
    Livingstone, E.
    Zimmer, L.
    ANNALS OF ONCOLOGY, 2012, 23 : 104 - 108
  • [48] How recent advances in immunotherapy are changing the standard of care for patients with metastatic melanoma
    Wolchok, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 15 - 21
  • [49] Recent treatment advances and novel therapies in pancreas cancer: A review
    Valsecchi M.E.
    Díaz-Cantón E.
    De La Vega M.
    Littman S.J.
    Journal of Gastrointestinal Cancer, 2014, 45 (2) : 190 - 201
  • [50] Recent Advances in Combination Treatments for Photoaging: Review of the Literature
    Tierney, Emily P.
    Hanke, C. William
    DERMATOLOGIC SURGERY, 2010, 36 (06) : 829 - 840
12345